Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06775912
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:31.616530+00:00
Published At
2026-02-02T00:00:00+00:00
Record Updated At
2026-02-02
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["SLE", "Systemic Sclerosis", "IIM", "NMOSD", "MS", "MG", "ANCA Associated Vasculitis (AAV)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-02"
protocolSection.identificationModule.nctId
"NCT06775912"
protocolSection.identificationModule.officialTitle
"Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • SLE (protocolSection.conditionsModule.conditions)
  • Systemic Sclerosis (protocolSection.conditionsModule.conditions)
  • IIM (protocolSection.conditionsModule.conditions)
  • NMOSD (protocolSection.conditionsModule.conditions)
  • MS (protocolSection.conditionsModule.conditions)
  • MG (protocolSection.conditionsModule.conditions)
  • ANCA Associated Vasculitis (AAV) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.